Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:57-64
Published online before print November 11, 2004, doi: 10.1161/01.ATV.0000150662.51436.14
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/1/57    most recent
01.ATV.0000150662.51436.14v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wruck, C. J.
Right arrow Articles by Unger, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wruck, C. J.
Right arrow Articles by Unger, T.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:57.)
© 2005 American Heart Association, Inc.


Vascular Biology

Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein

Christoph J. Wruck; Heiko Funke-Kaiser; Thomas Pufe; Heike Kusserow; Mario Menk; Jan H. Schefe; Marie L. Kruse; Monika Stoll; Thomas Unger

From the Institute of Pharmacology (C.J.W.) and the First Department of Medicine (M.L.K.), University Hospital Schleswig-Holstein, Campus Kiel; the Institute of Anatomy (T.P.), University of Kiel; the Center for Cardiovascular Research/Institute of Pharmacology and Toxicology (H.F.-K., H.K., M.M., J.H.S., T.U.), Charité–University Medicine Berlin; and the Institute for Arteriosclerosis Research at the University of Muenster (M.S.), Germany.

Correspondence to Thomas Unger, MD, Center for Cardiovascular Research/Institute of Pharmacology and Toxicology, Charité–University Medicine Berlin, Hessische Str. 3-4, 10115 Berlin, Germany. E-mail thomas.unger{at}charite.de

Objective— Synthesis and maturation of G protein–coupled receptors are complex events that require an intricate combination of processes including protein folding, posttranslational modifications, and transport through distinct cellular compartments. Little is known concerning the regulation of G protein–coupled receptor transport from the endoplasmic reticulum to the cell surface.

Methods and Results— Here we show that the cytoplasmatic carboxy-terminal of the angiotensin AT2 receptor (AT2R) acts independently as an endoplasmic reticulum–export signal. Using a yeast two-hybrid system, we identified a Golgi membrane–associated protein termed ATBP50 (for AT2R binding protein of 50 kDa) that binds to this motif. We also cloned ATBP60 and ATBP135 encoded by the same gene as ATBP50 that mapped to chromosomes 8p21.3. Downregulation of ATBP50 using siRNA leads to retention of AT2R in inner compartments, reduced cell surface expression, and decreased antiproliferative effects of the receptor.

Conclusion— Our results indicate that ATBP50 regulates the transport of the AT2R to cell membrane by binding to a specific motif within its cytoplasmic carboxy-terminal and thereby enabling the antiproliferative effects of the receptor.

We identified a Golgi membrane–associated protein termed ATBP50 that binds to the cytoplasmatic terminus of the angiotensin AT2 receptor. We also cloned ATBP60 and ATBP135 encoded by the same gene. Downregulation of ATBP50 leads to retention of AT2R in inner compartments, reduced cell surface expression, and decreased antiproliferative effects of AT2R.


Key Words: AT2 receptor • ATBP50 • receptor transport • Golgi proteins • ERK1/2


Related Article:

Beyond the G Protein: The Saga of the Type 2 Angiotensin II Receptor
E.J. Landon and T. Inagami
Arterioscler. Thromb. Vasc. Biol. 2005 25: 15-16. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Mogi, M. Iwai, and M. Horiuchi
Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2532 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo
Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Frank, J. L. Bermejo, K. Hemminki, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle-Bahat, P. Bugert, R. K. Schmutzler, C. R. Bartram, et al.
Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk
Carcinogenesis, July 1, 2007; 28(7): 1442 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J.-M. Li, M. Mogi, K. Tsukuda, H. Tomochika, J. Iwanami, L.-J. Min, C. Nahmias, M. Iwai, and M. Horiuchi
Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1
Mol. Endocrinol., February 1, 2007; 21(2): 499 - 511.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E.J. Landon and T. Inagami
Beyond the G Protein: The Saga of the Type 2 Angiotensin II Receptor
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 15 - 16.
[Full Text] [PDF]